Docusate Sodium
Product Images NDC 10544-130

1 FDA label image from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 10544-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg 20ct (Label Docusate Sodium Caps 100mg Bpi(10544 130 20) Sda(66424 030 10) Rev1)

100mg 20ct (Label Docusate Sodium Caps 100mg Bpi(10544 130 20) Sda(66424 030 10) Rev1)
Docusate Sodium Stool Softener 100 mg softgel capsules label from Blenheim Pharmacal, Inc. The label indicates a package of 20 softgel capsules with storage instructions and a note to see the package insert for dosage. The label includes NDC 10544-130-20 and manufacturer code 66424-030-10, along with warnings to keep out of reach of children and to ask a doctor before use if certain conditions are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.